EndoChoice (GI) Misses Q1 EPS by 13c

Go back to EndoChoice (GI) Misses Q1 EPS by 13c

New Clinical Evidence to be Presented on the Fuse® Full Spectrum Endoscopy® system at DDW® 2016

May 4, 2016 7:05 AM EDT

ALPHARETTA, Ga., May 4, 2016 /PRNewswire/ -- EndoChoice Holdings, Inc. (NYSE: GI) announced that the Company will participate at the Digestive Disease Week (DDW®) tradeshow, May 22-24 in San Diego, CA. The EndoChoice booth will be #4317.  Products from EndoChoice's Imaging, Devices, Diagnostics, and Infection Control portfolios... More